Health & Fitness Russia's Sputnik V vaccine 'works well against UK variant'
Half-dose of Oxford vaccine was NOT a 'mistake', scientists say
Oxford University's researchers have insisted they knew about the different dosing regimens and agreed everything with regulators before people were given the injectionsIn a hit back against claims that the team had accidentally given people the wrong doses of the vaccine, the researchers said they had known the doses would be smaller because of a manufacturing issue before they injected them.
Russia's Sputnik V vaccine is showing strong signs of effectiveness against new mutations of Covid-19, researchers have claimed.
The results of the trial in Russia testing the effectiveness of revaccination are expected to show a positive effect on protection against UK and South African strains of the virus, and will be published soon.
Denis Logunov, deputy director of the centre which developed the jab said: '(A) recent study carried out by the Gamaleya Centre in Russia showed that revaccination with Sputnik V vaccine is working very well against new coronavirus mutations, including the UK and South African strains of coronavirus.'
A Guide To The Covid-19 Vaccine If You're Pregnant Or Breastfeeding
People who are either pregnant and deemed high-risk from Covid-19, or breastfeeding, have now been given the go-ahead to have the Covid-19 vaccine in the UK – despite previously being told they shouldn’t have it. Although it seems like positive news, there hasn’t been a change in evidence in terms of the safety of such vaccines for these groups. It’s likely to be a confusing U-turn for those who were explicitly told they couldn’t have the vaccine and were gearing up to batten down the hatches for months while carrying their baby, and possibly years after, if breastfeeding.So what do you need to know?Related...
Last month Vladimir Putin ordered a review by March 15 of Russian-produced vaccines for their effectiveness against new variants spreading in different parts of the world.
It comes after the President green-lit its approval for mass-use in Russia last August before any human trials had been rigorously analysed.
Highly-infectious South African Covid strain has yet to take off in UK
A top SAGE expert said today there was 'no evidence' of widespread community transmission of the South African variant - called 501.V2 - in the UK.The South African strain of coronavirus isn't spreading rapidly through the UK, No10's scientific advisers said today in a bid to calm fears about the super-infectious variant.
The 68-year-old has played down suggestions he should get the vaccine immediately to encourage public takeup, telling journalists that 'I don't want to monkey around' in front of cameras.
The jab was today being rolled out in countries including Mexico, Paraguay and Venezuela.
Video: Vaccine research: Drug companies developing vaccines to fight new strains (France 24)
Results of the trial are expected to be published soon, but this was the first indication of how the tests are going. No further details were available yet.
So-called viral vector shots - such as Sputnik V and a shot developed by AstraZeneca - use harmless modified viruses as vehicles, or vectors, to carry genetic information that helps the body build immunity against future infections.
The revaccination used the same Sputnik V shot, based upon the same adenovirus vectors. The trial indicated this did not impact effectiveness, Logunov said in a statement to Reuters.
Kent variant may be deadlier because it multiplies faster in lungs
Britain's Covid fight was dealt another blow on Friday when Boris Johnson revealed the new variant was about 30 per cent more lethal than the virus which first came out of China. It had been known for weeks that the Kent variant was far more infectious than the original strain, thanks to a mutation on its spike protein which makes it easier for the virus to bind to human cells. But Professor Peter Horby, a senior SAGE expert and an epidemiologist at Oxford University, said today the mutations which make it more transmissible could also be behind its increased lethality.He said: 'If you’re getting much stronger binding...
Some scientists have raised the possible risk that the body also develops immunity to the vector itself, recognising it as an intruder and trying to destroy it.
But developers of Sputnik V disagreed this would pose long-term problems.
'We believe that vector-based vaccines are actually better for future revaccinations than vaccines based on other platforms,' Logunov said.
He said that the researchers found that antibodies specific to the vectors used by the shot - which could generate an anti-vector reaction and undermine the work of the shot itself - waned 'as early as 56 days after vaccination'.
This conclusion was based on a trial of a vaccine against Ebola developed earlier by the Gamaleya Institute using the same approach as for the Sputnik V shot.
Vector immunity is not a new issue but has come under renewed scrutiny as companies including Johnson & Johnson anticipate regular COVID-19 vaccinations, like annual influenza shots, may be needed to combat new variants of the coronavirus.
Is the AstraZeneca vaccine safe for young women? Why do countries keep banning it? .
ASTRAZENECA Covid vaccine has been banned in a number of countries for people under 60 years old, including Germany and Canada, over blood clot fears in younger women. Is the AstraZeneca/Oxford Covid vaccine safe to use, and why do countries keep banning it?Germany and Canada have decided to suspend the use of the vaccine for all young people, over concerns about blood clots.